US FDA concludes inspection at Unichem Lab's Ghaziabad unit

Unichem Laboratories’ formulations manufacturing facility at Ghaziabad has received an Establishment Inspection Report from the US Food and Drug Administration, indicating closure of inspection. The inspection was conducted by the USFDA in April, the company said in a notice to the stock exchanges. Shares of Unichem Laboratories closed at ₹232.90, down 2.69 per cent, on the NSE.